You are here

Novartis cancer drug may also work for Parkinson's

Monday, October 19, 2015 - 05:50

A small dose of the Novartis drug Tasigna was found to produce "meaningful clinical improvements" in 10 out of 11 patients with Parkinson's disease.


A NOVARTIS AG drug used for treating leukemia may also work for patients with Parkinson's disease, judging from one small and early clinical test.

An early stage trial conducted by the Georgetown University Medical Center found a small dose of the medicine, Tasigna, produced

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom